Item 2.02. Results of Operations and Financial Condition.

On August 5, 2021, Provention Bio, Inc. (the "Company") issued a press release regarding financial results for the fiscal quarter ended June 30, 2021 and discussing its business outlook. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Current Report on Form 8-K under this Item 2.02, including the information contained in Exhibit 99.1, is being furnished to the Securities and Exchange Commission, and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by a specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) The following exhibit is furnished with this report:





Exhibit No.   Description

99.1            Press Release issued by Provention Bio, Inc. on August 5, 2021
104           Cover Page Interactive Data File (formatted as Inline XBRL)

© Edgar Online, source Glimpses